Long-term result of endoscopic Histoacryl&reg; (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 11

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 21, 2011; 17(11): 1494-1500
Published online Mar 21, 2011. doi: 10.3748/wjg.v17.i11.1494

Table 6 Predictive factors of rebleeding within 1 year

Clinical characteristics	Rebleeding	Non rebleeding	P
Sex			0.597
Male	17	80
Female	6	24
Etiology			0.707
Hepatitis B	11	39
Hepatitis C	2	8
Alcoholic	6	6
Unknown	4	4
Association of hepatocellular carcinoma			0.000
Yes	9	12
No	14	92
Sarin classification of gastro-esophageal varices			0.009
GOV1	8	48
GOV2	15	46
Form of gastric varices			0.269
F1	1	14
F2	11	45
F3	11	44
Duration			0.815
< 24 h	17	80
> 24 h	6	24
CTP grade			0.230
A	6	36
B	9	52
C	8	16

GOV: Gastro-esophageal varices.

Citation: Kang EJ, Jeong SW, Jang JY, Cho JY, Lee SH, Kim HG, Kim SG, Kim YS, Cheon YK, Cho YD, Kim HS, Kim BS. Long-term result of endoscopic Histoacryl^® (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices. World J Gastroenterol 2011; 17(11): 1494-1500
URL: https://www.wjgnet.com/1007-9327/full/v17/i11/1494.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i11.1494

Kang EJ, Jeong SW, Jang JY, Cho JY, Lee SH, Kim HG, Kim SG, Kim YS, Cheon YK, Cho YD, Kim HS, Kim BS. Long-term result of endoscopic Histoacryl^® (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices. World J Gastroenterol 2011; 17(11): 1494-1500 [PMID: 21472110 DOI: 10.3748/wjg.v17.i11.1494]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.